Technical Analysis Since early December, we have had over a dozen tails on the purple up-trend arrow drawn in. The 50sma is now coming into play, as a break below that, could take us another 20% down to the 100sma. An appropriate level to exit the trade then, would be below the 50sma. There also horizontal support as we fill the gap. Important Note:...
Did $ARKG just put in a short term top? $97 bound. C-Dub fans - please don't hate on me. This Eth is going to $200+ eventually but could use a ABC correction. Start loading in the $90s if we see it.
BNGO PT Q1 25$ Q2 35$ Q3 50$ Q4 75$ 2022 120$ 2023 300$ Once in a lifetime oppurtunity don't miss out, genomics will be the leading sector in market gains.
Atara Biotherapeutics , Inc. (Nasdaq: ATRA ), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T- cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune diseases "Atara made significant progress in 2020 and is well-positioned for a strong 2021," said...
BNGO (Bionano Genomics) is forming a textbook bull flag. This comes on the heels of a share offering, which is important. Share offerings dilute the value of the stock in the short term, but if general sentiment remains bullish, provides a buying opportunity for a takeoff after the retracement. Well, now we also have a bullish continuation pattern in the form of a...
$BNGO can go ahead and hit $10 real quick. Your comments are welcome. ############## Legal disclaimer: I am not a financial advisor. The advice here given is not a financial advice even though my excitement might make it look like such. This account shouldn't be followed by anyone expecting something from me. You trade at your own risk and nobody can guarantee...
Cup and Handle viewed on weekly chart.
#CRSP CRSP NASDAQ:CVAC SWB:8EM
ARKG broke out of the parallel channel with strong volume (over 110% tan average 10-day volume). When there is a break-out, the 5sma tends to be a good rule of thumb to follow the short-term trend; and not lose to much if there is a failed breakout. RSI shows we are still not overbought at 67; but with strong buying. Using the bottom level of the parallel...
BioNano Genomics, Inc. is a life sciences instrumentation company, which focuses on genome analysis space. Net Income $-29,820,000.00 Market Cap $69.23 million Annual Sales $10.13 million BNGO exceeded EARNINGS ESTIMATES in Q1 and on 7/17/2020 Maxim Group Reiterated the Rating to Buy and a target of $2.00 per share. If you are interested to test some amazing buy...
ILMN is one of the highest conviction picks by ARKK investments (ARKK). They invest in disruptive technology that could potentially change the world. Another pick Invitae(NVTA) has a similar pattern and broke out recently. Level exhaustion at the $372 level and a potential accumulation zone. A daily close above 372 would be bullish. An overall bullish sentiment...
#quantumgenomics $ALQGC MACD crossing, lots of catalysts coming to propel this stock higher and higher!
The deep freeze has taken over small cap land. It has been a long time since small caps were out of vogue but the time has come. As the great rotation of capital shifts from high risk stocks to low risk, high dividend payers, many think the end has come for any investments in small caps. I am here to say that is not true. Over the past year, you could have closed...